Publication | Open Access
High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer
31
Citations
18
References
2018
Year
STMN1 evaluation could be a useful progression marker, and STMN1 may be a promising candidate for targeted therapies in PDAC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1